483
Montefiore's Institute for Reproductive Medicine and HealthMontefiore's Institute for Reproductive Medicine and Health – FDA 483, May 3, 2019
Record Details
An FDA inspection of Montefiore's Institute for Reproductive Medicine and Health in Hartsdale, NY, revealed two significant observations related to human reproductive tissue. The firm failed to properly determine and document the eligibility of oocyte donors, specifically by not testing for West Nile Virus. Additionally, the firm's standard operating procedures for egg donor screening were not revised to include seasonal West Nile Virus testing.
- Inspection date
- May 3, 2019
- Product type
- biologics
View Company Profile
ID · 8ec76984-a358-47fb-a632-f8ae5e62b858
Other documents for Montefiore's Institute for Reproductive Medicine and Health
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.